๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Society of Academic and Research Surgery


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
107 KB
Volume
91
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

โœฆ Synopsis


Background: Ischaemia-reperfusion injury (IRI) is a major cause of morbidity which may be minimized by pharmacological preconditioning. Calcium has been shown to protect cardiac muscle from IRI as well as from arrhythmia related to hyperkalaemia. Cromakalim (K + channel opener) was shown to preserve skeletal muscle microcirculation after ischaemia. The effects of both treatments on the definitive endpoint of muscle infarction were compared. Methods: Twenty-four adult male Sprague-Dawley rats (300-350 g) were divided into four groups (n = 6) (licensed Home Office approved). Tourniquet occlusion of the right thigh for 2โ€ข5 h was followed by 3โ€ข5 h of reperfusion. Heart rate, blood pressure, temperature and tissue oxygenation were monitored throughout. At the end of the experiment the tibialis anterior muscle was harvested to assess the size of muscle infarction. Group I (IRI): 2โ€ข5 h ischaemia and 3โ€ข5 h reperfusion without preceding preconditioning; group II: as for group I, preceded by three cycles of 2โ€ข5 min of ischaemia preconditioning (IPC); group III: as for group I, preceded by the administration of calcium chloride; group IV: as for group I, preceded by K + channel opener (levocromakalim). Results: Values for mean(s.d.) muscle infarction area (MMIA) are shown in the Table .

MMIA (%)

*Significant difference.

Conclusion:

Calcium preconditioning increases the extent of damage in ischaemic skeletal muscle and should be used with caution in reperfusion injury. K + channel opener pretreatment significantly reduced IRI and merits further study.


๐Ÿ“œ SIMILAR VOLUMES


Society of Academic and Research Surgery
๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 127 KB

## SARS abstracts 1213 index. Splenocytes were harvested from test and control mice 2 weeks following PT removal. Antitumour cytotoxicity assessed by co-culturing splenocytes with viable 3LL tumour cells. Tumour cell death was assessed using Cytoxilux fluorogenic caspase assay. P < 0โ€ข05 using ANOV